Latest Headlines

Latest Headlines

NIH funds 5 projects to treat blindness, unveils Alzheimer's research agenda

The U.S. National Institutes of Health's National Eye Institute is spending up to $17.9 million over the next 5 years to find new therapies for blindness. In addition, the NIH just unveiled its Alzheimer's disease research agenda.

Congress keeps trial data sharing plan in slimmed-down 21st Century Cures Act

Legislation that would mandate the creation of a system to share de-identified clinical trial data has moved a step closer to coming into force. The text is included in the latest draft of the 21st Century Cures Act, which is almost 200 pages shorter than the original proposal.

Startup raises $4M for sterilization with vaporized hydrogen peroxide

Sterilucent has raised almost $4 million just about 6 months after the FDA cleared its Sterilucent PSD-85 Hydrogen Peroxide Sterilizer for use in healthcare facilities with tough surroundings such as combat hospitals and disaster response sites.

NIH awards $11M to develop tests for drug-resistant bacteria

The U.S. National Institutes of Health is funneling more than $11 million toward 9 research programs developing rapid diagnostics for antimicrobial resistance, a week after the Obama administration announced a plan to prioritize point-of-care testing to curtail the rise of drug-resistant bacteria.

Duke University scores $20M from NIH to develop HIV vaccine

In a win for HIV vaccine research, Duke University researchers have scored $20 million in grants from the National Institutes of Health to develop an HIV vaccine.

Efforts at intracochlear drug delivery to treat hearing loss gaining momentum

The millimeters-wide opening of the inner ear has long stymied efforts at drug delivery, but progress is being made, according to Scientific American. Draper Lab is working to create a small intracochlear device designed to treat hearing loss.

Study: Few clinical trial results posted on federal website as required by law

Only 13% of clinical trials registered at ClinicalTrials.gov posted their results within one year of data collection, as required by federal law, according to a study in The New England Journal of Medicine.

NIH puts data stitching at top of precision medicine to-do list

The National Institutes of Health (NIH) has put the establishment of a way to combine data from different sources at the top of its list of initial priorities for President Obama's precision medicine initiative. Such a system is essential if the NIH is to pull off its plan of making use of data generated by third parties.

UPDATED: NIH funds studies of J&J's and GSK's injectable HIV meds, says daily pills lead to noncompliance

In bid to improve patient adherence, the U.S. National Institutes of Health is funding and helping run two clinical trials of long-acting injectable HIV candidates being developed by Johnson & Johnson's Janssen and GlaxoSmithKline.

NIH proposes a large-scale collaborative research effort into nondrug pain management

The National Center for Complementary and Integrative Health at the National Institutes of Health (NIH) has proposed conducting large research studies of nondrug pain management approaches. It did so in a report by a working group of the Center's Advisory Council.